- Home
- SXTP vs BJDX Comparison
SXTP vs BJDX Comparison
Compare SXTP & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | BJDX |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 2.2M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SXTP | BJDX |
|---|---|---|
| Price | $0.85 | $1.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.40 | N/A |
| AVG Volume (30 Days) | 82.1K | ★ 111.2K |
| Earning Date | 11-13-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,364,945.00 | N/A |
| Revenue This Year | $146.28 | N/A |
| Revenue Next Year | $24.61 | $55.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 202.10 | N/A |
| 52 Week Low | $0.84 | $1.04 |
| 52 Week High | $11.35 | $10.20 |
Technical Indicators
Market Signals| Indicator | SXTP | BJDX |
|---|---|---|
| Relative Strength Index (RSI) | 26.58 | 30.14 |
| Support Level | $0.84 | $1.13 |
| Resistance Level | $0.98 | $1.30 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 4.93 | 3.61 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.